NextCure, Inc. (NXTC)
NASDAQ: NXTC · IEX Real-Time Price · USD
6.02 -0.18 (-2.90%)
Nov 26, 2021 1:00 PM EST - Market closed
Ratios and Metrics (Annual)
Market cap in millions USD. Fiscal year is January - December.
| Year | 2020 | 2019 |
|---|---|---|
| Market Capitalization | 300 | 1,282 |
| Market Cap Growth | -76.57% | - |
| Enterprise Value | 19 | 950 |
| PE Ratio | -8.21 | -37.99 |
| PS Ratio | 13.42 | 201.94 |
| PB Ratio | 1.02 | 3.99 |
| P/FCF Ratio | -5.77 | -32.87 |
| P/OCF Ratio | -6.68 | -35.98 |
| EV/Sales Ratio | 12.51 | 200.96 |
| EV/EBITDA Ratio | -8.44 | -41.08 |
| EV/EBIT Ratio | -7.65 | -37.81 |
| EV/FCF Ratio | -5.38 | -32.71 |
| Debt / Equity Ratio | 0.01 | 0.02 |
| Debt / EBITDA Ratio | -0.10 | -0.16 |
| Debt / FCF Ratio | -0.07 | -0.13 |
| Current Ratio | 27.89 | 22.60 |
| Asset Turnover | 0.07 | 0.03 |
| Return on Equity (ROE) | -11.70% | -21.80% |
| Return on Assets (ROA) | -11.30% | -14.70% |
| Return on Capital (ROIC) | -12.50% | -26.00% |
| Earnings Yield | -12.19% | -2.63% |
| FCF Yield | -17.34% | -3.04% |
| Buyback Yield / Dilution | -75.41% | -1045.78% |
| Total Shareholder Return | -75.41% | -1045.78% |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).